The effect of hormone therapy on chronic inflammation of endometriosis

The effect of hormone therapy on chronic inflammation of endometriosis - The effect of Dienogest on chronic inflammation of endometriosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032406

Enrollment

Registered

2018-04-27

Start date

2018-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inpatient for hysterectomy can be informed consent

Exclusion criteria

Exclusion criteria: intaking hormone therapy except Dienogest pregnancy women

Design outcomes

Primary

Measure	Time frame
To assess the number of immune cells especially regulatory T cells	—

Secondary

Measure	Time frame
To assess the amount of inflammatory cytokines by ELISA or realtime PCR	—

Countries

Japan

Contacts

Public ContactTakuya Sugahara

Kyoto Prefectural University of Medicine Obstetrics and Gynecology

sghr-tky@koto.kpu-m.ac.jp075-251-5560

Outcome results